ACCOLADE INC (ACCD) Stock Price, Forecast & Analysis

NASDAQ:ACCD • US00437E1029

7.02 USD
-0.01 (-0.14%)
At close: Apr 7, 2025
7.02 USD
0 (0%)
After Hours: 4/7/2025, 8:11:12 PM

ACCD Key Statistics, Chart & Performance

Key Statistics
Market Cap575.57M
Revenue(TTM)446.72M
Net Income(TTM)-180.30M
Shares81.99M
Float79.29M
52 Week High9.67
52 Week Low3.08
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.06
PEN/A
Fwd PEN/A
Earnings (Next)04-23
IPO2020-07-02
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
ACCD short term performance overview.The bars show the price performance of ACCD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80

ACCD long term performance overview.The bars show the price performance of ACCD in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of ACCD is 7.02 USD. In the past month the price increased by 0.86%. In the past year, price decreased by -14.91%.

ACCOLADE INC / ACCD Daily stock chart

ACCD Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ACCD. When comparing the yearly performance of all stocks, ACCD turns out to be only a medium performer in the overall market: it outperformed 44.41% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
ACCD Full Technical Analysis Report

ACCD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACCD. The financial health of ACCD is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ACCD Full Fundamental Analysis Report

ACCD Financial Highlights

Over the last trailing twelve months ACCD reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS increased by 35.76% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -27.85%
ROE -57.6%
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%-10.71%
Sales Q2Q%5.73%
EPS 1Y (TTM)35.76%
Revenue 1Y (TTM)14.99%
ACCD financials

ACCD Forecast & Estimates

16 analysts have analysed ACCD and the average price target is 6.83 USD. This implies a price decrease of -2.7% is expected in the next year compared to the current price of 7.02.

For the next year, analysts expect an EPS growth of -8.14% and a revenue growth 13.05% for ACCD


Analysts
Analysts53.75
Price Target6.83 (-2.71%)
EPS Next Y-8.14%
Revenue Next Year13.05%
ACCD Analyst EstimatesACCD Analyst Ratings

ACCD Ownership

Ownership
Inst Owners82.6%
Ins Owners3.24%
Short Float %N/A
Short RatioN/A
ACCD Ownership

ACCD Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.5998.152B
CI THE CIGNA GROUP8.9775.329B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2798.824.421B
LH LABCORP HOLDINGS INC15.6923.418B
DGX QUEST DIAGNOSTICS INC19.2522.519B
GH GUARDANT HEALTH INC N/A13.706B
DVA DAVITA INC11.410.1B
BTSG BRIGHTSPRING HEALTH SERVICES29.977.358B
CHE CHEMED CORP18.526.685B
OPCH OPTION CARE HEALTH INC18.725.66B

About ACCD

Company Profile

ACCD logo image Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

Company Info

ACCOLADE INC

660 W. Germantown Pike Suite 500

Plymouth Meeting PENNSYLVANIA 98101 US

CEO: Rajeev Singh

Employees: 2400

ACCD Company Website

ACCD Investor Relations

Phone: 16108342989

ACCOLADE INC / ACCD FAQ

What does ACCD do?

Accolade, Inc. engages in the provision of technology-enabled health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2020-07-02. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. The company also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.


What is the current price of ACCD stock?

The current stock price of ACCD is 7.02 USD. The price decreased by -0.14% in the last trading session.


Does ACCD stock pay dividends?

ACCD does not pay a dividend.


How is the ChartMill rating for ACCOLADE INC?

ACCD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


How is the valuation of ACCOLADE INC (ACCD) based on its PE ratio?

ACCOLADE INC (ACCD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).


What is ACCOLADE INC worth?

ACCOLADE INC (ACCD) has a market capitalization of 575.57M USD. This makes ACCD a Small Cap stock.